Evidence map›Paper›PMID 37125252›Full record

ReviewJGH open : an open access journal of gastroenterology and hepatology2023

Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment.

Daniel R A Cox, William Chung, Josephine Grace, Darren Wong, Numan Kutaiba, Dinesh Ranatunga, Richard Khor, Marcos V Perini, Michael Fink, Robert Jones and 4 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JGH open : an open access journal of gastroenterology and hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Daniel R A CoxDepartment of Surgery (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-5092-4370
William ChungDepartment of Medicine (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-8624-318X
Josephine GraceDepartment of Medicine (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-8435-4740
Darren WongDepartment of Medicine (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0003-1490-0547
Numan KutaibaDepartment of Radiology Austin Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0003-4627-9847
Dinesh RanatungaDepartment of Radiology Austin Health Melbourne Victoria Australia.
Richard KhorDepartment of Radiation Oncology Austin Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-7057-2747
Marcos V PeriniDepartment of Surgery (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-0165-1564
Michael FinkDepartment of Surgery (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-9684-4691
Robert JonesDepartment of Surgery (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-8415-5565
Mark GoodwinDepartment of Radiology Austin Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-1476-0591
Alex DobrovicDepartment of Surgery (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0003-3414-112X
Adam TestroDepartment of Medicine (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0001-6776-3115
Vijayaragavan MuralidharanDepartment of Surgery (Austin Precinct) The University of Melbourne Melbourne Victoria Australia.ORCID https://orcid.org/0000-0001-8247-8937
The University of Melbourne · AUAustin Health · AULa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is an aggressive primary malignancy of the liver and is the third most common cause of cancer-related global mortality. There has been a steady increase in treatment options for HCC in recent years, including innovations in both curative and non-curative therapies. These advances have brought new challenges and necessary improvements in strategies of disease monitoring, to allow early detection of HCC recurrence. Current serological and radiological strategies for post-treatment monitoring and prognostication and their limitations will be discussed and evaluated in this review.

Indexed as

alpha‐fetoproteindes‐γ‐carboxyprothrombinhepatocellular carcinomalens culinaris agglutinin‐A‐reactive α‐fetoproteinloco‐regional therapymicrowave ablationprotein induced by vitamin K absence or antagonist‐IIradiofrequency ablationtrans‐arterial chemo‐embolizationα‐fetoprotein

Identifiers

PMID37125252
PMCPMC10134770
OpenAlexW4362585624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.